• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.16% Nasdaq Up0.25%

    Sanofi (SNY)

    -NYSE
    49.29 Down 0.12(0.24%) Jun 1, 4:04PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Sanofi
    54, Rue La Boétie
    Paris, 75008
    France - Map
    Phone: 33 1 53 77 40 00
    Fax: 33 1 53 77 42 96
    Website: http://www.sanofi.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:113,496

    Business Summary 

    Sanofi researches, develops, and markets various therapeutic solutions. Its products comprise diabetes solutions, including Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-1 receptor agonist; and Afrezza, an inhaled insulin to improve glycemic control, as well as Toujeo, an insulin glargine. The company also offers Cerezyme to treat gaucher disease; Myozyme/Lumizyme for the pompe disease treatment; Fabrazyme for fabry disease treatment; and Aldurazyme to treat mucopolysaccharidosis type I, as well as provides Aubagio and Lemtrada for multiple sclerosis. In addition, it provides Jevtana for prostate cancer; Taxotere for the treatment of breast, non-small cell lung, prostate, gastric, and head and neck cancers; Thymoglobulin to treat acute rejection in organ transplantation, aplastic anemia, and graft-versus-host diseases; Eloxatin for colorectal cancer; Mozobil for treating hematologic malignancies; and Zaltrap for oxaliplatin resistant metastatic colorectal cancer. Further, the company offers other prescription drugs, such as Plavix for atherothrombosis and acute coronary syndrome; Lovenox for the treatment and prevention of deep vein thrombosis and acute coronary syndromes; Aprovel/CoAprovel for hypertension; Renagel/Renvela to treat chronic kidney disease; Depakine for epilepsy; Synvisc/Synvisc-One for the treatment of pain associated with osteoarthritis of the knee; Stilnox/Ambien/Myslee to treat sleep disorders; Multaq for atrial fibrillation; Allegra for the treatment of allergic rhinitis and urticarial; Actonel for osteoporosis and paget's disease; and Auvi-Q/Allerject for the treatment of severe allergic reactions. Additionally, it offers consumer health care products and generic medicines; and vaccine and animal health products. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Sanofi

    Key Executives 
     PayExercised
    Mr. Olivier Brandicourt , 59
    Chief Exec. Officer and Director
    N/AN/A
    Mr. Jérôme Contamine , 57
    Chief Financial Officer and Exec. VP
    N/AN/A
    Mr. Laurent Gilhodes ,
    Principal Accounting Officer and VP of Corp. Accounting
    N/AN/A
    Mr. Bruno Ménard ,
    Chief Information officer
    N/AN/A
    Mr. Sébastien Martel ,
    VP of Investor Relations
    N/AN/A
    Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.